Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study.
Biju GeorgeRajesh BalakrishnanPatricia SSharon LionelSushil SelvarajanAnup Joseph DevasiaAnu KorulaKavitha M LakshmiFouzia N AboobackerKulkarni Uday PrakashHenry Finlay GodsonJose Solomon RajAby AbrahamSelvamani BackianathanVikram MathewsPublished in: Clinical transplantation (2023)
The combination of TMLI and cyclophosphamide for myeloablative conditioning is associated with low toxicity and favorable early outcomes in patients undergoing HSCT for ALL and CML-LBC.